» Articles » PMID: 34078023

Implications of Oxidative Stress in Chronic Kidney Disease: a Review on Current Concepts and Therapies

Overview
Specialty Nephrology
Date 2021 Jun 2
PMID 34078023
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Moderate levels of endogenous reactive oxygen species (ROS) are important for various cellular activities, but high levels lead to toxicity and are associated with various diseases. Levels of ROS are maintained as a balance between oxidants and antioxidants. Accumulating data suggest that oxidative stress is a major factor in deterioration of renal function. In this review, we highlight the possible mechanism by which oxidative stress can lead to chronic kidney disease (CKD). This review also describes therapies that counter the effect of oxidative stress in CKD patients. Numerous factors such as upregulation of genes involved in oxidative phosphorylation and ROS generation, chronic inflammation, vitamin D deficiency, and a compromised antioxidant defense mechanism system cause progressive detrimental effects on renal function that eventually lead to loss of kidney function. Patients with renal dysfunction are highly susceptible to oxidative stress, as risk factors such as diabetes, renal hypertension, dietary restrictions, hemodialysis, and old age predispose them to increased levels of ROS. Biomolecular adducts (DNA, proteins, and lipids) formed due to reaction with ROS can be used to determine oxidative stress levels. Based on the strong correlation between oxidative stress and CKD, reversal of oxidative stress is being explored as a major therapeutic option. Xanthine oxidase inhibitors, dietary antioxidants, and other agents that scavenge free radicals are gaining interest as treatment modalities in CKD patients.

Citing Articles

Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study.

Wang X, Wu Z, He T, Chen X, Jin X, Zuo C Front Endocrinol (Lausanne). 2025; 15:1451954.

PMID: 39866738 PMC: 11757133. DOI: 10.3389/fendo.2024.1451954.


Protective Effects of Tormentic Acid on Unilateral Ureteral Obstruction-Induced Renal Injury, Inflammation, and Fibrosis: A Comprehensive Approach to Reducing Oxidative Stress, Apoptosis, and Ferroptosis.

Yang A, Kim J, Gwon M, Kwon H, Leem J, Jeon E Antioxidants (Basel). 2025; 14(1.

PMID: 39857346 PMC: 11762340. DOI: 10.3390/antiox14010013.


Iron Deficiency and Renal Phosphate Handling: The Role of Maximal Tubular Reabsorption of Phosphate Normalized to Glomerular Filtration Rate (TmP/GFR) in Proximal Tubular Dysfunction.

Yadav A, Narain U, Gupta A, Maurya S Cureus. 2025; 16(12):e76329.

PMID: 39850154 PMC: 11756918. DOI: 10.7759/cureus.76329.


Astragaloside IV attenuates cadmium induced nephrotoxicity in rats by activating Nrf2.

Li Y, Zhou J, Zhang T, Li X, Wu C, Zhao Z Sci Rep. 2025; 15(1):2028.

PMID: 39815001 PMC: 11735858. DOI: 10.1038/s41598-025-86312-4.


Neutrophil Extracellular Traps Drive Kidney Stone Formation.

Yang Z, Chen X, Qi G, Gu J, Liu Z, Zhang X Kidney Dis (Basel). 2025; 11(1):11-24.

PMID: 39759764 PMC: 11695979. DOI: 10.1159/000542471.


References
1.
Kao M, Ang D, Pall A, Struthers A . Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options. J Hum Hypertens. 2009; 24(1):1-8. DOI: 10.1038/jhh.2009.70. View

2.
Alvarez J, Law J, Coakley K, Zughaier S, Hao L, Shahid Salles K . High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012; 96(3):672-9. PMC: 3417221. DOI: 10.3945/ajcn.112.040642. View

3.
Karamouzis I, Sarafidis P, Karamouzis M, Iliadis S, Haidich A, Sioulis A . Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2007; 28(3):397-404. DOI: 10.1159/000112413. View

4.
Hollenberg N . Direct renin inhibition and the kidney. Nat Rev Nephrol. 2009; 6(1):49-55. DOI: 10.1038/nrneph.2009.201. View

5.
Gryp T, Vanholder R, Vaneechoutte M, Glorieux G . p-Cresyl Sulfate. Toxins (Basel). 2017; 9(2). PMC: 5331431. DOI: 10.3390/toxins9020052. View